Nov. 17, 2005 (Dallas) -- Several studies presented here at the American Heart Association 2005 Scientific Sessions show that aspirin has different effects on cardiovascular morbidity and mortality in ...

Miami, FL - A meta-analysis of five major randomized clinical trials involving a total of 55580 participants confirmed the cardiac benefit of aspirin, with a 32% risk reduction for first MI and a 15% ...

An analysis of previous studies indicates that use of aspirin significantly reduces the risk of cardiovascular events in women and in men, due to reducing the risk of stroke in women and reducing the ...

There have been conflicting views over the effects of aspirin over its more than 100 year reign as a diverse cure all to pain relief and preventative of heart disease and some cancers. Its mechanism ...

Please provide your email address to receive an email when new articles are posted on . In people with a family history of parental premature MI, aspirin for primary prevention was not associated with ...

Previous studies suggested a relationship between aspirin use and mortality reduction. The mechanism for the effect of aspirin on cancer outcomes remains unclear. The aim of this study was to evaluate ...

Please provide your email address to receive an email when new articles are posted on . “We have a number of highly effective medications available in prevention of cardiovascular disease in patients ...

ANAHEIM, CA—Aspirin should not be withheld prior to noncardiac surgery in patients with a history of PCI, even if their coronary procedure occurred years earlier, a new analysis from POISE-2 suggests.

Cardiovascular diseases, represented by myocardial infarction and cerebral infarction, are primarily caused by narrowed arteries and blood clots (thrombi) that block blood flow. Aspirin is known as a ...